Sutherland D E, Gruber S A
Department of Surgery, University of Minnesota Hospital and Clinic, Minneapolis.
Crit Care Clin. 1990 Oct;6(4):947-53.
Widespread application of pancreas transplantation in diabetic patients without secondary complications or without a demonstrated propensity to develop complications will not be possible until antirejection strategies with fewer side effects have been developed. For now, pancreas transplants are restricted to patients whose complications of diabetes are more serious than those associated with chronic immunosuppression and the drugs necessary to prevent rejection. In these individuals, however, pancreas transplantation should be considered an established therapeutic procedure.
在开发出副作用更少的抗排斥策略之前,胰腺移植在没有继发性并发症或没有表现出发生并发症倾向的糖尿病患者中广泛应用是不可能的。目前,胰腺移植仅限于那些糖尿病并发症比慢性免疫抑制及预防排斥所需药物相关并发症更严重的患者。然而,对于这些患者,胰腺移植应被视为一种既定的治疗方法。